KRTL BioTech

Latest News on private equity markets

Wall Street eases from record highs as Fed meeting looms

Wall Street's main indexes opened below their record highs on Monday, in a muted start to a week likely to be dominated by the Federal Reserve's policy stance and a round of tech company earnings that will again test the impact of trade concerns on global growth.



4 years ago

Wall Street falls as tech drags; Fed meeting eyed

U.S. stocks slid on Monday as technology shares fell in the run up to earnings from tech companies, which will test the impact of trade tensions on global growth, and ahead of the Federal Reserve's policy-setting meeting.



4 years ago

Morgan Stanley offers new tool to let advisors, investors measure sustainable investing goals

Morgan Stanley is using big data to help clients identify their sustainable investing choices and measure how well their portfolios track those goals.

4 years ago

Diagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal

Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers.



4 years ago

Oil gains on prospect of U.S. interest rate cut

Oil prices rose on Monday as the prospect of an expected interest rate cut by the U.S. Federal Reserve overshadowed pessimism over U.S.-China trade talks and oil demand fears stoked by forecasts for slower global economic growth.



4 years ago

Morgan Stanley: The S&P 500 will fail to break out for a third time in 18 months

Despite the S&P 500 closing at an all-time high on Friday, the index's internals and fundamentals are too weak to maintain the rally, Morgan Stanley said Monday.

4 years ago

Wall Street eases from record highs as tech drags; Fed meeting eyed

U.S. stocks retreated from record highs on Monday, weighed by technology shares ahead of high profile earnings including that of Apple, which will test the impact of trade tensions on global growth, ahead of the Federal Reserve's policy-setting meeting.



4 years ago

Pfizer in talks to transition EpiPen manufacturing into generics spinoff

Pfizer Inc is in talks to merge its contract manufacturer that produces Mylan's EpiPen emergency allergy treatment into the new generics business it has created by combining its older off-patent medicines unit with generic drugmaker Mylan NV , a Pfizer spokeswoman said.



4 years ago

Sterling tumbles on hard Brexit worries; stocks slip

The British pound on Monday touched its lowest against the dollar since early 2017 after Prime Minister Boris Johnson's government said it now assumed there would be a hard divorce from the EU, while stocks dipped globally after last week touching their highest in five months.



4 years ago

If you work at a small business and don't have access to a 401(k) plan, that could soon change

The Labor Department on Monday released a final rule that clarifies when businesses can band together to offer 401(k) plans through so-called association retirement plans.

4 years ago

Oil edges up on prospect of U.S. interest rate cut

Oil prices edged higher on Monday as the prospect of an expected interest rate cut by the U.S. Federal Reserve overshadowed pessimism over U.S.-China trade talks and worries about slower global economic growth.



4 years ago

FINRA fines Citigroup for loose background checks

The Financial Industry Regulatory Authority said on Monday it has fined Citigroup's Global Markets business $1.25 million for failing to perform proper background checks on thousands of employees between 2010 and 2017.



4 years ago

Pfizer to spinoff, merge off-patent drugs unit with Mylan

Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar.



4 years ago

Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman

Pfizer Inc is in talks to merge its contract manufacturer that produces Mylan's EpiPen emergency allergy treatment into the new generics business it is creating by combining its older off-patent medicines unit with Mylan NV , a Pfizer spokeswoman said.



4 years ago

Takeaway.com lands $10 billion Just Eat deal in food delivery race

Amsterdam-based Takeaway.com has agreed to buy Just Eat in an 8.2 billion pound ($10.1 billion) deal to create the world's largest online food delivery firm outside China in a race to rule the $100 billion market.



4 years ago